Image Credit:Iran J Pharm Res
Cisplatin Resistant Patterns in Ovarian Cell Line Using FTIR and Principle Component Analysis
Authors
Abstract
Cisplatin is a common chemotherapeutic agent that used for treatment of many solid cancers. Rapid identification of chemotherapy resistance is very important and may lead to effective treatment plan. Spectroscopy techniques, such as infrared spectroscopy, which are sensitive to biochemical composition of samples, have shown potentials to discriminate tissues. Developing in Fourier transform infrared (FTIR) as a diagnostic tool support conventional technique in investigating cell phenotype. By this goal three different cell lines, two cisplatin resistant OV2008-DDP (C13) and A2780-CP ovarian cell lines and one cisplatin sensitive A2780 cell line were investigated by FTIR spectroscopy. Data were subjected to principle component analysis (PCA) to obtain FTIR pattern for cisplatin resistance. Using FTIR spectroscopy on these cells in the range of 400-4000 cm-1 was shown dramatic change in cells. Results shows that Cisplatin resistance pattern is characterized in spectrum with the alteration of conformation in secondary structure of proteins and a shift toward the high wave numbers of CH2 stretching vibration. The FTIR data set between 1000 and 3000 cm-1 could be consumed as biochemical typicality spectra among resistant and sensitive cell lines while correctly classified by PCA model. Our work supports the promise of PCA analysis of FTIR data as a powerful combined approach for the development of automated methods to recognize resistant to cisplatin in experimental cell lines. One of the advantages of this tool is to investigate the resistant percent of cancer cells .Such technique may bring new tool in cancer diagnosis and stage definition in cancerous tissues.
Highlights
Acknowledgments
References
- 1.Rabik CA, Dolan ME. Molecular mechanisms of resistance and toxicity associated with platinating agents. Cancer Treat. Rev. 2007;33:9-23. [PubMed ID: 17084534].
- 2.Wadkins RM, Roepe PD. Biophysical aspects of P-glycoprotein-mediated multidrug resistance. Int. Rev. Cytol. 1997;171:121-165. [PubMed ID: 9066127].
- 3.Tewari KS, Monk BJ. Gynecologic oncology group trials of chemotherapy for metastatic and recurrent cervical cancer. Curr. Oncol. Rep. 2005;7:419-34. [PubMed ID: 16221379].
- 4.Kartalou M, Essigmann JM. Mechanisms of resistance to cisplatin. Mutat. Res. 2001;478:23-43. [PubMed ID: 11406167].
- 5.Siddik ZH. Cisplatin: mode of cytotoxic action and molecular basis of resistance. Oncogene. 2003;22:7265-79. [PubMed ID: 14576837].
- 6.Litman T, Druley TE, Stein WD, Bates SE. From MDR to MXR: new understanding of multidrug resistance systems, their properties and clinical significance. Cell. Mol. Life Sci. 2001;58:931-959. [PubMed ID: 11497241].
- 7.Holzer AK. Cisplatin rapidly down-regulates its own influx transporter hCTR1 in cultured human ovarian carcinoma cells. Clin. Cancer Res. 2004;10:6744-9. [PubMed ID: 15475465].
- 8.Shirazi FH Wong PTT, Goe R. Interaction of cisplatin with cellular macromolecules: A fourier transform infrared spectroscopy study. Iranian J. Pharm. Res. 2003;2:11-15.
- 9.Katano K. Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper. Cancer Res. 2002;62:6559-65. [PubMed ID: 12438251].
- 10.Safaei R. Abnormal lysosomal trafficking and enhanced exosomal export of cisplatin in drug resistant human ovarian carcinoma cells. Mol. Cancer Ther. 2005;4:1595-604. [PubMed ID: 16227410].
- 11.Ofir K, Kelly S, Yechiel S. Functional and structural characterization of HIV-1 gp41 ectodomain regions in phospholipid membranes suggests that the fusion-active conformation is extended. J. Mol. Biol. 2006;364:1103-1117. [PubMed ID: 17045292].
- 12.Krafft C, Sobottka B, Geiger D. Classification of malignant gliomas by infrared spectroscopic imaging and linear discriminate analysis. Anal. Bioanal. Chem. 2007;387:1669-1677. [PubMed ID: 17103151].
- 13.Hosseini Shirazi F, Vakili N, Abdi K, Farhadi A, Rahimi F. Fourier-Transform Infrared Spectroscopic comparison of normal and malignant cervical tissue. Iranian J. Pharm. Res. 2005;6:107-113.
- 14.Afrakhteh M, Khodakarami N, Moradi A, Alavi E, Hosseini Shirazi F. Papanicolau smear diagnoses in Shohada Hospital. J. Fam. Reproduc. Health. 2007;1:75-79.
- 15.Li GZ, Bu HL, Mary Qu Y, Xue-Qiang Z. Selecting subsets of newly extracted features from PCA and PLS inmicroarray data analysis. BMC Genomics. 2008;9:1-15. [PubMed ID: 18171476].
- 16.Safaak H. Spectroscopic study for detection and grading of breast carcinoma in-vitro. Aus. J. Basic Appl. Sci. 2009;3:2419-2428.
- 17.Baker MJ, Gazi E, Brown MD, Shanks JH, Gardner P, Clarke NW. FTIR-based spectroscopic analysis in the identification of clinically aggressive prostate cancer. Br. J. Cancer. 2008;99:1859-1866. [PubMed ID: 18985044].
- 18.Adam J. Characterization of human corneal stem cells by synchroton infrared micro-spectroscopy. Mol. Vision. 2007;13:237-42.
- 19.Katia Z, Christine RN, Frederic M. E6 proteins from diverse Papilloma viruses self-associate both in-vitro and in-vivo. J. Mol. Biol. 2010;396:90-104. [PubMed ID: 19917295].
- 20.Lugli E, Pinti M, Nasi M, Troiano L, Ferraresi R. Subject classication obtained by cluster analysis and principal component analysis applied to flow cytometric data. Cytometry Part A. 2007;71:334-344.
- 21.Maureen CM, Marianne D, Breeanna R. Neural network analyses of infrared spectra for classifying cell wall architectures. Plant Physiol. 2007;143:1314-1326. [PubMed ID: 17220361].
Copyright
© 2012 by School of Pharmacy, Shaheed Beheshti University of Medical Sciences and Health Services. This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Similar Articles
Patterns Prediction of Chemotherapy Sensitivity in Cancer Cell lines Using FTIR Spectrum, Neural Network and Principal Components Analysis
Zendehdel R, Masoudi-Nejad A, H. Shirazi F. Patterns Prediction of Chemotherapy Sensitivity in Cancer Cell lines Using FTIR Spectrum, Neural Network and Principal Components Analysis. Iran J Pharm Res. 2012;11(2):e125852. doi: https://doi.org/10.22037/ijpr.2012.1141
FTIR Biospectroscopy Investigation on Cisplatin Cytotoxicity in Three Pairs of Sensitive and Resistant Cell Line
Farhadi E, Kobarfard F, H. Shirazi F. FTIR Biospectroscopy Investigation on Cisplatin Cytotoxicity in Three Pairs of Sensitive and Resistant Cell Line. Iran J Pharm Res. 2016;15(1):e125097. doi: https://doi.org/10.22037/ijpr.2016.1775
Predicting of Effective Dose as Biomarker for Cytotoxicity Using Partial Least Square-Fourier Transform Infrared Spectroscopy (PLS_FTIR)
Zendehdel R, Khodakarim S, H. Shirazi F. Predicting of Effective Dose as Biomarker for Cytotoxicity Using Partial Least Square-Fourier Transform Infrared Spectroscopy (PLS_FTIR). Iran J Pharm Res. 2015;14(4):e125394. doi: https://doi.org/10.22037/ijpr.2015.1729
Interaction of Cisplatin with Cellular Macromolecules: A Fourier Transform Infrared Spectroscopy Study
H.Shirazi F, Wong PT, Goel R. Interaction of Cisplatin with Cellular Macromolecules: A Fourier Transform Infrared Spectroscopy Study. Iran J Pharm Res. 2022;2(1):e127602. doi: https://doi.org/10.22037/ijpr.2010.28
Metabolome profile comparison of cisplatin sensitive and resistant in ovarian epithelial cells by magnetic resonance spectroscopy spectroscopy
Akbari Z, Awsat Mellati AL, Amanzadeh A, Nazarian A, Zamani Z, et al. Metabolome profile comparison of cisplatin sensitive and resistant in ovarian epithelial cells by magnetic resonance spectroscopy spectroscopy. koomesh. 2016;17(4):e151182. doi:
- Scopus by DOI: 0
Last Update: 2 weeks ago
- Scopus by Title: 21
Last Update: 2 weeks ago
- Scopus by Title (Ref): 21
Last Update: 2 weeks ago
- CrossRef: 0
Last Update: 1 week ago
- OpenAlex: 0
Last Update: 11 hours ago
- OpenCitations: 0
Last Update: 4 days ago



